Brief: Study Shows Biocept's Assays Are Viable, Sensitive For Detecting Tumor Cells, Biomarkers In The Cerebrospinal Fluid Of Patients With Breast, Lung Cancer

Biocept

20/11/2020 13:08

Nov 20 (Reuters) - Biocept Inc  BIOC.O :
    * STUDY SHOWS BIOCEPT'S ASSAYS ARE VIABLE AND SENSITIVE FOR
DETECTING TUMOR CELLS AND BIOMARKERS IN THE CEREBROSPINAL FLUID
OF PATIENTS WITH BREAST AND LUNG CANCER THAT HAS METASTASIZED TO
THE CENTRAL NERVOUS SYSTEM

Source text for Eikon:  ID:nPnPh9zka 
Further company coverage:  BIOC.O 

 ((Reuters.Briefs@thomsonreuters.com;))